Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Thrombosis and Haemostasis|September 7, 1992
Tissue plasminogen activator release in chronic venous hypertension due to heart failureI Keber, D Keber, M Stegnar, et al.Thrombosis Research|November 15, 1991
Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosisM Stegnar, P Peternel, D Keber, et al.Obesity Research|September 15, 2001
Impact of weight reduction on early carotid atherosclerosis in obese premenopausal womenA Mavri, M Stegnar, J T Sentocnik, et al.Acta Neurologica Scandinavica|March 12, 2002
Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctionsB Salobir, M Sabovic, P Peternel, et al.Thrombosis Research|December 15, 1996
A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosisN Grubic, M Stegnar, P Peternel, et al.Die Pharmazie|November 17, 2004
Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitorsA Obreza, M Stegnar, A Trampus-Bakija, et al.Thrombosis Research|August 15, 1991
Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysisM Stegnar, B Bozic, P Peternel, et al.Thrombosis and Haemostasis|December 7, 1992
Lysing patterns of retracted blood clots with diffusion or bulk flow transport of plasma with urokinase into clots--a magnetic resonance imaging study in vitroA Blinc, D Keber, G Lahajnar, et al.Thrombosis and Haemostasis|September 1, 1993
Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperiumM Stegnar, A Zore, Z Novak-Antolic, et al.Die Pharmazie|May 9, 2007
Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitorsI Smolnikar, A Perdih, M Stegnar, et al.Pageof 4